257 related articles for article (PubMed ID: 26708754)
21. Skeletal muscle is enriched in hematopoietic stem cells and not inflammatory cells in cachectic mice.
Berardi E; Aulino P; Murfuni I; Toschi A; Padula F; Scicchitano BM; Coletti D; Adamo S
Neurol Res; 2008 Mar; 30(2):160-9. PubMed ID: 18397608
[TBL] [Abstract][Full Text] [Related]
22. The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia.
Bonetto A; Rupert JE; Barreto R; Zimmers TA
J Vis Exp; 2016 Nov; (117):. PubMed ID: 27929469
[TBL] [Abstract][Full Text] [Related]
23. Fuzheng Xiaoai Decoction 1 ameliorated cancer cachexia-induced muscle atrophy via Akt-mTOR pathway.
Cheng QQ; Mao SL; Yang LN; Chen L; Zhu JZ; Liu X; Hou AJ; Zhang RR
J Ethnopharmacol; 2023 Mar; 303():115944. PubMed ID: 36410574
[TBL] [Abstract][Full Text] [Related]
24. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
[TBL] [Abstract][Full Text] [Related]
25. Pantoprazole blocks the JAK2/STAT3 pathway to alleviate skeletal muscle wasting in cancer cachexia by inhibiting inflammatory response.
Guo D; Wang C; Wang Q; Qiao Z; Tang H
Oncotarget; 2017 Jun; 8(24):39640-39648. PubMed ID: 28489606
[TBL] [Abstract][Full Text] [Related]
26. Administration of adiponectin receptor agonist AdipoRon relieves cancer cachexia by mitigating inflammation in tumour-bearing mice.
Massart IS; Kouakou AN; Pelet N; Lause P; Schakman O; Loumaye A; Abou-Samra M; Deldicque L; Bindels LB; Brichard SM; Thissen JP
J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):919-933. PubMed ID: 38572511
[TBL] [Abstract][Full Text] [Related]
27. Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscle.
Pretto F; Ghilardi C; Moschetta M; Bassi A; Rovida A; Scarlato V; Talamini L; Fiordaliso F; Bisighini C; Damia G; Bani MR; Piccirillo R; Giavazzi R
Oncotarget; 2015 Feb; 6(5):3043-54. PubMed ID: 25460504
[TBL] [Abstract][Full Text] [Related]
28. Voluntary exercise does not improve muscular properties or functional capacity during C26-induced cancer cachexia in mice.
Hiroux C; Dalle S; Koppo K; Hespel P
J Muscle Res Cell Motil; 2021 Jun; 42(2):169-181. PubMed ID: 33606189
[TBL] [Abstract][Full Text] [Related]
29. ActRII blockade protects mice from cancer cachexia and prolongs survival in the presence of anti-cancer treatments.
Hatakeyama S; Summermatter S; Jourdain M; Melly S; Minetti GC; Lach-Trifilieff E
Skelet Muscle; 2016; 6():26. PubMed ID: 27462398
[TBL] [Abstract][Full Text] [Related]
30. c9t11-Conjugated linoleic acid-rich oil fails to attenuate wasting in colon-26 tumor-induced late-stage cancer cachexia in male CD2F1 mice.
Tian M; Kliewer KL; Asp ML; Stout MB; Belury MA
Mol Nutr Food Res; 2011 Feb; 55(2):268-77. PubMed ID: 20827675
[TBL] [Abstract][Full Text] [Related]
31. Aerobic Exercise and Pharmacological Treatments Counteract Cachexia by Modulating Autophagy in Colon Cancer.
Pigna E; Berardi E; Aulino P; Rizzuto E; Zampieri S; Carraro U; Kern H; Merigliano S; Gruppo M; Mericskay M; Li Z; Rocchi M; Barone R; Macaluso F; Di Felice V; Adamo S; Coletti D; Moresi V
Sci Rep; 2016 May; 6():26991. PubMed ID: 27244599
[TBL] [Abstract][Full Text] [Related]
32. Prevention of cancer cachexia by pyrrolidine dithiocarbamate (PDTC) in colon 26 tumor-bearing mice.
Nai YJ; Jiang ZW; Wang ZM; Li N; Li JS
JPEN J Parenter Enteral Nutr; 2007; 31(1):18-25. PubMed ID: 17202436
[TBL] [Abstract][Full Text] [Related]
33. Combined Exercise Training Positively Affects Muscle Wasting in Tumor-Bearing Mice.
Ranjbar K; Ballarò R; Bover Q; Pin F; Beltrà M; Penna F; Costelli P
Med Sci Sports Exerc; 2019 Jul; 51(7):1387-1395. PubMed ID: 30724848
[TBL] [Abstract][Full Text] [Related]
34. Dietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic mice.
van Norren K; Kegler D; Argilés JM; Luiking Y; Gorselink M; Laviano A; Arts K; Faber J; Jansen H; van der Beek EM; van Helvoort A
Br J Cancer; 2009 Mar; 100(5):713-22. PubMed ID: 19259092
[TBL] [Abstract][Full Text] [Related]
35. Improvement of chemotherapy through reducing of cachexia by using Citrus unshiu peel extract.
Tahaghoghi-Hajghorbani S; Ebrahimzadeh MA; Rafiei A; Golpour M; Hosseini-Khah Z; Akhtari J
J Ethnopharmacol; 2019 Oct; 242():111929. PubMed ID: 31054317
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of the renin-angiotensin system improves physiological outcomes in mice with mild or severe cancer cachexia.
Murphy KT; Chee A; Trieu J; Naim T; Lynch GS
Int J Cancer; 2013 Sep; 133(5):1234-46. PubMed ID: 23436228
[TBL] [Abstract][Full Text] [Related]
37. Curcumin Targeting NF-
Zhang J; Zheng J; Chen H; Li X; Ye C; Zhang F; Zhang Z; Yao Q; Guo Y
Mediators Inflamm; 2022; 2022():2567150. PubMed ID: 35132306
[TBL] [Abstract][Full Text] [Related]
38. [Role of NF-kappa B in cancer cachexia].
Zhou W; Jiang ZW; Jiang J; Li N; Li JS
Zhonghua Wai Ke Za Zhi; 2004 Jun; 42(11):683-6. PubMed ID: 15329260
[TBL] [Abstract][Full Text] [Related]
39. Moderate exercise in mice improves cancer plus chemotherapy-induced muscle wasting and mitochondrial alterations.
Ballarò R; Beltrà M; De Lucia S; Pin F; Ranjbar K; Hulmi JJ; Costelli P; Penna F
FASEB J; 2019 Apr; 33(4):5482-5494. PubMed ID: 30653354
[TBL] [Abstract][Full Text] [Related]
40. Pre-cachexia in patients with stages I-III non-small cell lung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system.
Op den Kamp CM; Langen RC; Minnaard R; Kelders MC; Snepvangers FJ; Hesselink MK; Dingemans AC; Schols AM
Lung Cancer; 2012 Apr; 76(1):112-7. PubMed ID: 22018880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
